<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>KETOCONAZOLE- ketoconazole cream </strong><br>Preferred Pharmaceuticals, Inc.<br></p></div>
<h1><span class="Bold">KETOCONAZOLE CREAM</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_0ab086a6-2093-4930-8266-b823a401e41c"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Ketoconazole Cream, 2% contains the broad-spectrum synthetic antifungal agent, ketoconazole 2%. Each gram, for topical administration, contains ketoconazole 20 mg and is formulated in an aqueous cream vehicle consisting of propylene glycol, purified water, cetyl alcohol, stearyl alcohol, isopropyl myristate, sorbitan monostearate, polysorbate 60, polysorbate 80, and sodium sulfite, anhydrous:</p>
<p>Ketoconazole is <span class="Italics">cis</span>-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1<span class="Italics">H</span>-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine and has the following structural formula:</p>
<div class="Figure">
<a name="id221"></a><img alt="ketoconazole structural formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7a18a4f4-5487-4cf6-a46d-58369dc5833c&amp;name=7a18a4f4-5487-4cf6-a46d-58369dc5833c-01.jpg">
</div>
<p>C<span class="Sub">26</span>H<span class="Sub">28</span>Cl<span class="Sub">2</span>N<span class="Sub">4</span>O<span class="Sub">4</span>          M.W. 531.44</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_4a1d38c8-e9a7-4af9-ba56-0e7abf86d194"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">When ketoconazole cream, 2% was applied dermally to intact or abraded skin of Beagle dogs for 28 consecutive days at a dose of 80 mg, there were no detectable plasma levels using an assay method having a lower detection limit of 2 ng/ml.</p>
<p>After a single topical application to the chest, back and arms of normal volunteers, systemic absorption of ketoconazole was not detected at the 5 ng/ml level in blood over a 72-hour period.</p>
<p>Two dermal irritancy studies, a human sensitization test, a <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">phototoxicity</span> study and a photoallergy study conducted in 38 male and 62 female volunteers showed no contact sensitization of the delayed <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> type, no irritation, no <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">phototoxicity</span> and no photoallergenic potential due to ketoconazole cream, 2%.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_d15ac1b0-485b-4261-918e-ebea05dd189a"></a><a name="section-2.1"></a><p></p>
<h2>Microbiology</h2>
<p class="First">Ketoconazole is a broad spectrum synthetic antifungal agent which inhibits the <span class="Italics">in vitro</span> growth of the following common dermatophytes and yeasts by altering the permeability of the cell membrane: dermatophytes: <span class="Italics">Trichophyton rubrum</span>, <span class="Italics">T. mentagrophytes</span>, <span class="Italics">T. tonsurans</span>, <span class="Italics">Microsporum canis</span>, <span class="Italics">M. audouini</span>, <span class="Italics">M. gypseum</span> and <span class="Italics">Epidermophyton floccosum</span>; yeasts: <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> albicans</span>, <span class="Italics">Malassezia ovale (Pityrosporum ovale)</span> and <span class="Italics">C. tropicalis</span>; and the organism responsible for <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span>, <span class="Italics">Malassezia furfur (Pityrosporum orbiculare)</span>. Only those organisms listed in the INDICATIONS AND USAGE Section have been proven to be clinically affected. Development of resistance to ketoconazole has not been reported.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_49e36abd-9ae8-418a-b57f-5a3b934785b3"></a><a name="section-2.2"></a><p></p>
<h2>Mode of Action</h2>
<p class="First"><span class="Italics">In vitro</span> studies suggest that ketoconazole impairs the synthesis of ergosterol, which is a vital component of fungal cell membranes.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_56541c66-6898-4762-89bf-669ad15a4bed"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Ketoconazole Cream, 2% is indicated for the topical treatment of <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> corporis, <span class="product-label-link" type="condition" conceptid="4160328" conceptname="Tinea cruris">tinea cruris</span> and <span class="product-label-link" type="condition" conceptid="133141" conceptname="Tinea pedis">tinea pedis</span> caused by <span class="Italics">Trichophyton rubrum</span>, <span class="Italics">T. mentagrophytes</span> and <span class="Italics">Epidermophyton floccosum</span>; in the treatment of <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> (pityriasis) versicolor caused by <span class="Italics">Malassezia furfur (Pityrosporum orbiculare)</span>; and in the treatment of cutaneous <span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">candidiasis</span> caused by <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> spp</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_267ed4a6-c889-48f8-bf23-a22e61f71064"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Ketoconazole Cream, 2% is contraindicated in persons who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to the active or excipient ingredients of this formulation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_67dd8445-b2bb-4a7d-a7ae-b973e9614788"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Ketoconazole Cream, 2% is not for opthalmic use.</p>
<p>Ketoconazole Cream, 2% contains sodium sulfite anhydrous, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> than in nonasthmatic people.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_220c35d1-8dd6-4c9e-87e5-02c0f5cd6e04"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_5d0d9cce-6899-41ea-8aa0-a9f5e7776b28"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">If a reaction suggesting sensitivity or chemical irritation should occur, use of the medication should be discontinued. <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">Hepatitis</span> (1:10,000 reported incidence) and, at high doses, lowered testosterone and ACTH induced corticosteroid serum levels have been seen with orally administered ketoconazole; these effects have not been seen with topical ketoconazole.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_77bbc2b0-3cee-4776-ba16-5710b9a5db48"></a><a name="section-6.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">A long-term feeding study in Swiss Albino mice and in Wistar rats showed no evidence of oncogenic activity. The dominant lethal mutation test in male and female mice revealed that single oral doses of ketoconazole as high as 80 mg/kg produced no mutation in any stage of germ cell development. The Ames’ <span class="Italics"><span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span></span> microsomal activator assay was also negative.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_a561dc89-716c-4acf-8d9b-f7a516f4b623"></a><a name="section-6.3"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="i4i_teratogenic_id_43ec5091-b8eb-4a94-98c1-4e269d60267e"></a><a name="section-6.3.1"></a><p></p>
<h3><span class="Bold">Teratogenic effects</span></h3>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_84e58075-967c-46c5-a0e3-978ccbe40967"></a><a name="section-6.3.1.1"></a><p></p>
<h4><span class="Bold">Pregnancy Category C</span></h4>
<p class="First">Ketoconazole has been shown to be teratogenic (syndactylia and oligodactylia) in the rat when given orally in the diet at 80 mg/kg/day, (10 times the maximum recommended human oral dose). However, these effects may be related to maternal toxicity, which was seen at this and higher dose levels.</p>
<p>There are no adequate and well-controlled studies in pregnant women. Ketoconazole should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_b54ba3c0-5995-4f62-b641-6de54cc44383"></a><a name="section-6.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether ketoconazole cream, 2% administered topically could result in sufficient systemic absorption to produce detectable quantities in breast milk. Nevertheless, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_17ad1e87-5587-4ad7-8415-db02cbb5603b"></a><a name="section-6.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in children have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_9cc129ed-1dcf-46af-a2aa-df61ddb2e608"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">During clinical trials 45 (5%) of 905 patients treated with ketoconazole cream, 2% and 5 (2.4%) of 208 patients treated with placebo reported side effects consisting mainly of severe irritation, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>. One of the patients treated with ketoconazole cream developed a painful <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span>.</p>
<p>In worldwide postmarketing experience, rare reports of <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span> have been associated with ketoconazole cream or one of its excipients, namely sodium sulfite or propylene glycol.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_e91b13e5-5fa0-405e-ae19-895944be3001"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><span class="Italics">Cutaneous <span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">candidiasis</span>, <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> corporis, <span class="product-label-link" type="condition" conceptid="4160328" conceptname="Tinea cruris">tinea cruris</span>, <span class="product-label-link" type="condition" conceptid="133141" conceptname="Tinea pedis">tinea pedis</span>, and <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> (pityriasis) versicolor:</span> It is recommended that ketoconazole cream, 2% be applied once daily to cover the affected and immediate surrounding area. Clinical improvement may be seen fairly soon after treatment is begun; however, <span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">candidal infections</span> and <span class="product-label-link" type="condition" conceptid="4160328" conceptname="Tinea cruris">tinea cruris</span> and corporis should be treated for two weeks in order to reduce the possibility of recurrence. Patients with <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span> usually require two weeks of treatment. Patients with <span class="product-label-link" type="condition" conceptid="133141" conceptname="Tinea pedis">tinea pedis</span> require six weeks of treatment.</p>
<p>If a patient shows no clinical improvement after the treatment period, the diagnosis should be redetermined.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_bc26f6a2-3bc1-430e-b1fa-0c248f516504"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Ketoconazole Cream, 2% is supplied as</p>
<p>15gr tube - 68788-9507-1</p>
<p>30gr tube - 68788-9507-3</p>
<p>Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].</p>
<p>Manufactured In Croatia By:</p>
<p><span class="Bold">PLIVA HRVATSKA d.o.o.</span></p>
<p>Zagreb, Croatia</p>
<p>Manufactured For:</p>
<p><span class="Bold">TEVA PHARMACEUTICALS USA</span></p>
<p>Sellersville, PA 18960</p>
<p>Rev. C 3/2005</p>
<p><span class="Bold">Relabeled by Preferred Pharmaceuticals, Inc.</span></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_9f19ea03-cba5-4911-b386-1c697cd8f88d"></a><a name="section-10"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<div class="Figure">
<a name="id421"></a><img alt="Ketoconazole Cream 2%" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7a18a4f4-5487-4cf6-a46d-58369dc5833c&amp;name=7a18a4f4-5487-4cf6-a46d-58369dc5833c-02.jpg">
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_9c25c345-752c-4310-bfbc-aebeb32c1173"></a><a name="section-10.1"></a><p></p>
<h2>Ketoconazole Cream 2%</h2>
<p class="First"><span class="Bold">KETOCONAZOLE CREAM 2%</span></p>
<p>For dermatologic use only</p>
<p><span class="Bold">Rx only</span></p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>KETOCONAZOLE 		
					</strong><br><span class="contentTableReg">ketoconazole cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:68788-9507(NDC:0093-0840)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>KETOCONAZOLE</strong> (KETOCONAZOLE) </td>
<td class="formItem">KETOCONAZOLE</td>
<td class="formItem">20 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CETYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SORBITAN MONOSTEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYSORBATE 60</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYSORBATE 80</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM SULFITE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:68788-9507-1</td>
<td class="formItem">15 g in 1 TUBE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:68788-9507-3</td>
<td class="formItem">30 g in 1 TUBE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA075581</td>
<td class="formItem">02/28/2014</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Preferred Pharmaceuticals, Inc.
							(791119022)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Preferred Pharmaceuticals, Inc. (791119022)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Preferred Pharmaceuticals, Inc.</td>
<td class="formItem"></td>
<td class="formItem">791119022</td>
<td class="formItem">RELABEL(68788-9507)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 1/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>c17b06a8-94c1-41e5-8ef1-22105ad4a060</div>
<div>Set id: 7a18a4f4-5487-4cf6-a46d-58369dc5833c</div>
<div>Version: 2</div>
<div>Effective Time: 20150121</div>
</div>
</div> <div class="DistributorName">Preferred Pharmaceuticals, Inc.</div></p>
</body></html>
